Alira Health

Alira Health

Management Consulting

Commercial Strategy and Go-to-Market Model

In-depth market intelligence for your business

With a full team of global specialists, you’ll get a granular view of market intelligence, research and trends. Receive in-depth, actionable insights on all areas of your business, including revenue, sales volume, product mix, supply chain, distribution channels, R&D, and manufacturing.

Tailored strategy, planning, and execution

The successful realization of commercial potential requires the combination of a precise strategy with a robust go-to-market model. At Alira Health, our team of global specialists designs both specifically for your business.

From the beginning, we’ll help you define strategic goals, identify critical success factors needed to achieve those goals, and plan the commercial and scientific actions to realize them.

We’ll help you determine which organizational capabilities will be critical to your success, and insight on whether those should be developed internally or accessed through third-party partnerships. Our extensive, world-wide network of healthcare, pharma, and MedTech organizations helps us connect you with the right partners.

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • Market-leading and global specialists with diverse industry and advisory experience
  • Our nuanced understanding of both the customer and competitive space to deliver strategic guidance and go-to-market model development

Connect with a Winning Team

See why Alira Health was named one of the world’s best management consulting firms by Forbes.

Related news

Articles July 4, 2024
Navigating Market Access for Rare Diseases: The Potential of Real-World Evidence
Our experts answer common questions about the strategic need for real-world evidence to drive market access for rare diseases.
Market Access Rare Disease Real-World Evidence (RWE)
Case Studies June 27, 2024
A Multinational Pharma Targeting Myasthenia Gravis Garners Payer Advice on Market Access
Our client sought to incorporate early payer advice on the MG clinical trial design, identify evidence gaps, and provide insights on the overall development program for the asset.
Market Access Myasthenia Gravis (MG) Rare Disease
Articles March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
News January 18, 2024
Alira Health and Biocat Announce Startup Support Program for 2024
Alira Health and Biocat, a strategic stakeholder building the Catalan life sciences and ecosystem, partnered to foster Market Access for startups.
Market Access Startups
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.